• Home
  • About
  • Drug Development Pipeline
  • News
  • Investors
  • Careers
  • Contact
  • TSX.V: RKV
  • FSE: 7JO0
  • OTCMKTS: RKVTF

Rakovina Therapeutics Announces Results from 2025 Annual General Meeting

by Rakovina Therapeutics | Jun 26, 2025 | Uncategorized

Download Vancouver, British Columbia, June 25, 2025 – Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0) (“Rakovina” or the “Company”), a biopharmaceutical company advancing next-generation cancer therapies through artificial intelligence (AI)-powered drug discovery...

Rakovina Therapeutics Announces Share Consolidation Effective Date

by Rakovina Therapeutics | Jun 20, 2025 | Uncategorized

Download VANCOUVER, B.C., June 20, 2025 – Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE:7JO) (“Rakovina” or the “Company”) is pleased to announce that the effective date for the previously announced share consolidation (the...

Rakovina Therapeutics to Attend BIO International Convention to Advance Strategic Partnering Opportunities

by Rakovina Therapeutics | Jun 20, 2025 | Uncategorized

Download Vancouver, British Columbia – June 12, 2025 – Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO) (“Rakovina” or the “Company”), a biopharmaceutical company advancing innovative cancer therapies through artificial intelligence (AI)-powered drug discovery,...

Rakovina Therapeutics Announces the Closing of Oversubscribed Private Placement of $4.9 Million

by Rakovina Therapeutics | Jun 20, 2025 | Uncategorized

Download Vancouver, British Columbia – June 6, 2025 – Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO) (“Rakovina” or the “Company”), a biopharmaceutical company advancing innovative cancer therapies through artificial intelligence (AI)-powered drug discovery,...

Rakovina Therapeutics Announces 2025 Q1 Financial Results and Provides Corporate Update

by Rakovina Therapeutics | Jun 2, 2025 | Uncategorized

All dollar amounts reflected in Canadian dollars unless otherwise stated. Vancouver, British Columbia, June 2, 2025 – Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO) (“Rakovina” or the “Company”), a biopharmaceutical company advancing novel DNA-damage response...
« Older Entries
Next Entries »

Suite 720, 999 West Broadway, Vancouver, British Columbia
Canada V5Z 1K5

Home

About

Drug Development Pipeline

News

Investors

Careers

Contact

Company Disclosure

Privacy Policy

Subscribe

To Receive Company Updates

Copyright ©2020-2026 Rakovina Therapeutics Inc. All rights reserved.  | Privacy Policy | Terms of Use |  Site by Vanooms Media